Abstract
Polyaspartamides conjugates and co-conjugates containing platinum(II) complex and bisphosphonate were synthesized by stepwise reaction of polysuccinimide with selected primary amines. The first step was achieved by aminolytic ring opening of polysuccinimide and afforded conjugates containing bisphosphonate and dihydroxylato ligand for platinum chelation. In the second step conjugates were chelated to platinum(II) complex. These conjugates and co-conjugates were characterized by proton and phosphorus nuclear magnetic resonance (1H and 31P NMR), Fourier transform spectroscopy (FTIR), scanning electron microscope (SEM) and energy-dispersive X-ray analysis (EDX). The mass percentage incorporation of platinum in the co-conjugates was determined by ICP-OES and was found to be between 1.9 and 3.7 percent, while the mass percentage incorporation of bisphosphonate in the conjugates and co-conjugates was found to be between 2.5 and 3.1 percent by NMR. The preliminary pharmacological evaluation performed on co-conjugates 4, 5 and 6 revealed that co-conjugate 6 exhibited enhanced antimalarial activity than chloroquine, while co-conjugates 4 and 5 were less active.
Similar content being viewed by others
References
Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, Valencia ME, Abella E, López-Guillermo A, Sureda A, Morgades M, Navarro JT, Esteban H (2007) GESIDA Group; GELCAB Group. Haematologica 92:191–198
Sitzia J, Huggins L (1998) Cancer Pract. 6:13–21
Duncan R, Vicent MJ, Greco F, Nicholson RI (2005) Endocr Relat Cancer 12:S189–S199
Dabrowiak JC (2009) Metals in medicine, chap. 6. Wiley, UK
Navarro M, Castro W, Madamet M, Amalvict R, Benoit N, Pradines B (2014) Malaria J. 13:471–479
Dorsey G, Nyama D, KanyaM R, Cattmanchi A, Kyabayine D, Staedka SG, Gasasira A, Rosenthal PJ (2002) Lancet 360:2031–2038
Lefevre G, Looareesuwan S, Treprasertsun S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R, Am J (2001) Trop. Med. Hyg. 64:247–256
Sannela AR, Casini A, Gabbiani C, Messori L, Bilia AR, Vincieri FF (2008) FEBS Lett 582:844–847
Rafique S, Idrees M, Nasim A, Akbar H, Athar A (2010) Biotechnol Mol Biol Rev 5(2):38–45
Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP (2010) Curr Pharm Des 16(27):2950–2960
Koba M, Koba K, Przyborowski L (2008) Acta Pol Pharm 65(3):289–294
Walsh JP (2004) Med J Aust 181(5):262–265
Nugent CA, Gall EP, Pitt MJ (1984) Prim Care 11(2):353–368
Russell RGG, Rogers MJ (1999) Bone 25(1):97–106
Singh AP, Zhang Y, No JH, Docampo R, Nussenzweig V, Oldfield E (2010) Antimicrob Agents Chemother 54(7):2987–2993
Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JMW, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E (2006) J Med Chem 49(1):215–223
Porras AH, Holland SD, Gertz BJ (1999) Clin Pharmacokinet 35(5):315–328
Khosla S, Bilezikian JP, Dempster DW, Lewiecki ME, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT (2012) J Clin Endocrinol Metab 97(7):2272–2282
Dumitriu S, Dumitriu M (1994). In: Dumitriu S (ed) Polymeric biomaterials. Marcel Dekker, New York
Dunn L, Ottenbrite RM (eds) (1991) Polymeric drug and drug delivery systems. ACS Symposium Series, Birmingham, p 469
Takura Y, Hashida M (1995) Crit Rev Oncol Hematol 18:207231
Pietersz GA (1990) Bioconjugate Chem. 1:89–95
Ouchi T, Ohya Y (1995) Prog Polym Sci 20:211–257
Gabison A (1989). In: Roerdink FHD, Kroon AM (eds) Drug carrier systems, vol 9. Wiley, New York, pp 185–212
Brannonpeppas L (1995) Int J Pharm 116:1–9
Kerr DJ, Kaye SB (1991) CRC Crit Rev Ther Drug Carrier Syst 8:19–39
Yang MB, Tamargo RJ, Brem H (1989) Cancer Res 49:5103–5107
Springer CJ, Bagshawe KD, Sharma SK, Searle F, Sherwood RF, Melton RG, Eur J (1991) Cancer 27:1361–1366
Neuse EW (2004). Abd-el-Aziz AS, Carraher CE Jr, Pittman CU Jr, Sheats JE, Zeldin M (eds) In: Macromolecules containing metal and metal-like elements, 3: Biomedical applications, chap. 6. Wiley, New York
Pasut G, Veronese FM (2007) Prog Polym Sci 32:933–961
Aderibigbe BA (2015) J Inorg Organomet Polym 25:339–353
Neri P, Antoni F (1982) Macromol Synt 8:25
Hoeschele JD, Farrell N, Turner WR, Rithner CD (1988) Inorg Chem 27:4106
Hayat F, Moseley E, Salahuddin A, Van Zyl RL, Azam A (2011) Eur J Med Chem 46(5):1897
Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC (1926) Antimicrob Agents Chemother 51(6):1926
Van Zyl RL, Khan F, Edwards TJ, Drewes SE (2008) S Afr J Sci 104(1–2):62
Acknowledgement
The financial assistance of the University of Johannesburg toward this research is hereby acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mukaya, H.E., van Zyl, R.L., van Vuuren, N.J. et al. Synthesis and characterization of water-soluble polyaspartamides containing platinum(II) complex and bisphosphonate as potential antimalarial drug. Polym. Bull. 74, 3161–3178 (2017). https://doi.org/10.1007/s00289-016-1886-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00289-016-1886-x